Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT06440642 |
Other study ID # |
2023/51,1/250/33 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
June 1, 2024 |
Est. completion date |
July 31, 2024 |
Study information
Verified date |
May 2024 |
Source |
Dr. Lutfi Kirdar Kartal Training and Research Hospital |
Contact |
Irem DURMUS, MD, Specialist |
Phone |
05449306949 |
Email |
irem.durmus89[@]gmail.com |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational [Patient Registry]
|
Clinical Trial Summary
A total of 50 patients aged between 18-60 years, classified as American Society of
Anesthesiologists (ASA) I-II, undergoing elective total laparoscopic hysterectomy in the
steep trendelenburg position (STP) will be included in the study. Preoperatively, an
ophthalmologist will perform an eye examination on the patients, and intraocular pressure
will be measured using a non-contact computerized tonometer (Topcon CT-800, Japan). Central
corneal thickness and iridocorneal angle will be measured using a topography device (Sirius
Topography, CSO, Italy), and the thickness of the retinal nerve fiber layer (RNFL) will be
measured using an optical coherence tomography (OCT) device (DRI OCT Triton, Topcon, Japan).
Patients' demographic data and operation durations will be recorded. Intraocular pressure
(IOP) will be measured in the supine position after intubation (T1), during pneumoperitoneum
(T2), in the steep Trendelenburg position (23°, head down) (T3), at the end of the operation
when pneumoperitoneum is terminated (T4), after returning to the supine position (T5), and 10
minutes after returning to the supine position (T6). Simultaneously with IOP measurements,
the patients' hemodynamic data (Blood pressure, heart rate, end-tidal CO2, partial
saturation) will be recorded.
Description:
This study is planned to be conducted in the operating room of Kartal Dr. Lütfi Kırdar City
Hospital between June 2024 and July 2024. A total of 50 patients aged between 18-60 years,
classified as ASA I-II, undergoing elective total laparoscopic hysterectomy in the steep
Trendelenburg position will be included in the study. Patients who are under 18 years or over
60 years, classified as ASA III or above, or have pre-existing eye conditions causing
intraocular pressure changes such as glaucoma or ocular hypertension, cranial tumors, or any
conditions that may be affected by increased intracranial pressure will not be included in
the study.
All patients will undergo a preoperative evaluation the day before surgery, and written
informed consent will be obtained for participation in the study. Patients who agree to
participate will have an eye examination performed by an ophthalmologist preoperatively.
Intraocular pressure (IOP) will be measured using a non-contact computerized tonometer
(Topcon CT-800, Japan). Central corneal thickness and iridocorneal angle will be measured
using a topography device (Sirius Topography, CSO, Italy), and the thickness of the retinal
nerve fiber layer (RNFL) will be measured using an optical coherence tomography (OCT) device
(DRI OCT Triton, Topcon, Japan).
Sure, here is the translation of your text into English:
---
The anesthesia protocol will be standardized for the drugs used during the procedure.
Standard anesthesia induction will be provided with 2 mg IV midazolam, 3 mg/kg IV propofol,
100 mcg IV fentanyl, and 0.8 mg/kg IV rocuronium. Sevoflurane at 1 Minimum Alveolar
Concentration (MAC) will be used for anesthesia maintenance. While the patient is in the
supine position, intraperitoneal CO2 insufflation will be used to create pneumoperitoneum.
The patients will then be placed in the steep Trendelenburg position (25 degrees from
horizontal) at the maximum Trendelenburg angle (STP). All procedures will be performed in the
same operating room, on the same table, and at the same angle. Intraperitoneal pressure will
be maintained at 15 mm Hg throughout the surgery. At the end of the operation, patients will
be awakened and transferred to the recovery unit. In the recovery unit, patients will be
monitored for at least 30 minutes.
Intraocular pressure (IOP) will be measured in the supine position using a contact handheld
tonometer (TONO-PEN AVIA, Reichert, USA). The Tono-pen is chosen for its speed, the ability
to measure across multiple patients with single-use latex tip covers, ease of use, accuracy,
and reliability in various positions. Five consecutive measurements will be taken for each
eye. If the variability between consecutive measurements exceeds 5%, the measurements will be
repeated. The average of the five measurements will be taken for each measurement. All
measurements will be performed by the same ophthalmologist. All surgical operations will be
conducted in the morning or early afternoon to prevent diurnal variations in IOP. All
surgeries will be performed by the same surgical team.
The demographic data of the patients and the durations of the operations will be recorded.
IOP will be measured in the supine position after intubation (T1), during pneumoperitoneum
(T2), when placed in STP (23° head down) (T3), at the end of the operation when
pneumoperitoneum is terminated (T4), after being placed back in the supine position (T5), and
10 minutes after being placed back in the supine position (T6). Simultaneously with IOP
measurements, the patients' hemodynamic data (blood pressure, heart rate, end-tidal CO2,
partial saturation) will be recorded.